Expectations of Rate Hikes by Fed and BOJ Rise, US Bond Yields Break Key Threshold, Short-Term Pressure Mounts on Risk Assets
BlockBeats News, May 17th. As of Friday's close, the yield on the 10-year U.S. Treasury bond surged to a one-year high of 4.530%, surpassing the 4.50% policy inflection point that former President Trump had intervened in multiple times.
On the other hand, changes in the Fed's leadership and macroeconomic data have led to an increasing expectation of rate hikes, with the possibility of a rate cut now seemingly completely ruled out. At the same time, the market is highly anticipating a rate hike decision by the Bank of Japan in June (with a probability as high as 80% on Polymarket).
Furthermore, SpaceX's massive fundraising and renewed tensions between the U.S. and Iran are adding to the uncertainty. These factors are also expected to have a significant impact on market liquidity and confidence.
Considering all these factors, risk assets are likely to face significant pressure in the short term. Unless strong measures are taken to reverse the situation, Friday's widespread decline may just be the beginning of an adjustment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
